WUGEN
Company Overview
Social Media Profiles
About Wugen
Description
Wugen Oncology is a biotechnology company focused on developing innovative off-the-shelf cell therapies. Specializing in allogeneic CAR-T and memory NK cell treatments, Wugen is dedicated to transforming cancer care through advanced engineered therapies targeting various hematologic malignancies and solid tumors.
Specialties
Allogeneic CAR-T therapies
Memory NK cell treatments
Off-the-shelf cell therapies
Targeting hematologic malignancies
Solid tumor therapies
Products & Services
Allogeneic CAR-T therapies
Memory NK cell therapies
Cancer immunotherapy
Oncology research and development
Clinical trial services
Contact Information
No contact information available
Competitors & Similar Companies(9)
CARMA Health
Texas, • United States
Celyad Oncology
Zymeworks
British Columbia, • Canada
Allogene Therapeutics
California, • United States
Adicet Bio
California, • United States
Pliant Therapeutics
Fate Therapeutics
California, • United States
Agenus
Massachusetts, • United States
Kite Pharma
California, • United States
News & Media
Search Terms:
wugen
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Wugen
Where is Wugen located?
The headquarter of Wugen is located in Saint Louis, Missouri, United States
What is the official website of Wugen?
The official website of Wugen is https://www.wugen.com
What industry does Wugen belong to?
Wugen belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Wugen?
Wugen specializes in Allogeneic CAR-T therapies, Memory NK cell treatments, Off-the-shelf cell therapies, Targeting hematologic malignancies, Solid tumor therapies.
What products and services is Wugen likely to offer?
Wugen offers Allogeneic CAR-T therapies, Memory NK cell therapies, Cancer immunotherapy, Oncology research and development, Clinical trial services.
Who are the competitors of Wugen?
Competitors of Wugen are CARMA Health, Celyad Oncology, Zymeworks, Allogene Therapeutics, Adicet Bio, Pliant Therapeutics, Fate Therapeutics, Agenus, Kite Pharma.
What does Wugen do?
Wugen Oncology is a biotechnology company focused on developing innovative off-the-shelf cell therapies. Specializing in allogeneic CAR-T and memory NK cell treatments, Wugen is dedicated to transforming cancer care through advanced engineered therapies targeting various hematologic malignancies and solid tumors.